- Home
- TNGX vs FIVN Comparison
TNGX vs FIVN Comparison
Compare TNGX & FIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | FIVN |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TNGX | FIVN |
|---|---|---|
| Price | $16.29 | $17.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 19 |
| Target Price | $17.50 | ★ $26.32 |
| AVG Volume (30 Days) | ★ 3.5M | 2.9M |
| Earning Date | 06-01-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.89 | ★ 364.71 |
| EPS | N/A | ★ 0.45 |
| Revenue | $62,384,000.00 | ★ $1,149,088,000.00 |
| Revenue This Year | N/A | $11.39 |
| Revenue Next Year | $13.81 | $10.00 |
| P/E Ratio | ★ N/A | $40.24 |
| Revenue Growth | ★ 48.29 | 10.28 |
| 52 Week Low | $1.04 | $15.70 |
| 52 Week High | $17.63 | $31.75 |
Technical Indicators
Market Signals| Indicator | TNGX | FIVN |
|---|---|---|
| Relative Strength Index (RSI) | 69.95 | 49.60 |
| Support Level | $10.90 | $16.46 |
| Resistance Level | N/A | $18.96 |
| Average True Range (ATR) | 1.16 | 1.14 |
| MACD | 0.44 | 0.11 |
| Stochastic Oscillator | 79.65 | 38.54 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.